Prof. Nur Olgun is a pediatric hematology and oncology specialist with a medical degree from Dokuz Eylul University (1998). With a career that includes affiliation with Acibadem Health Group (2025), Prof. Olgun brings extensive clinical experience in childhood cancer care and research. Active in national and international professional communities, memberships include the Turkish Medical Association, Turkish Pediatric Oncology Group (TPOG), Turkish Cancer Research and Fight Foundation, and the Izmir Branch of the Turkish Cancer Research and Fighting Organization. International affiliations include the International Society of Paediatric Oncology (SIOP), the International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN), and the Pediatric Oncology East and Mediterranean (POEM) Group. Committed to improving outcomes for children with cancer, Prof. Olgun combines clinical practice, collaboration across research networks, and advocacy within the pediatric oncology field.
Education
- 1998 Dokuz Eylul University Faculty of Medicine, Pediatric Hematology and Oncology
- 1995 Dokuz Eylul University, Institute of Oncology, Professor Doctor
- 1989 Dokuz Eylul University, Institute of Oncology, Associate Professor
- 1984 Dokuz Eylul University Faculty of Medicine Pediatrics
- 1979 Ege University Faculty of Medicine
Experience
- 2025 Acibadem Health Group
- 2025 Dokuz Eylul University, Institute of Oncology, Pension
- 1992 – 2025 Dokuz Eylul University, Institute of Oncology, Faculty Member, Institute Director
- 2022 – 2024 Dokuz Eylul University, Faculty of Medicine, Dean
- 2012 – 2024 Dokuz Eylul University, Institute of Oncology, Institute Director
- 1985 – 1992 Dokuz Eylül University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Oncology, Faculty Member
Memberships
- Turkish Medical Association
- International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN)
- The Pediatric Oncology East and Mediterranean (POEM) Group
- Turkish Pediatric Oncology Group (TPOG) Association
- Turkish Cancer Research and Fight Foundation
- International Society of Paediatric Oncology (SIOP)
- Turkish Cancer Research and Fighting Organization, Izmir Branch
Publications
- Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes
J Clin Med. 2025 Jan 31;14(3):934 Olgun N, Arayici ME, Kizmazoglu D, Cecen RE. - Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study.
Ann Clin Transl Neurol. 2024 Aug;11(8):2153-2165. Kum Özşengezer S, Altun ZS, Sanlav G, Baran B, Kızmazoğlu D, Aktaş S, Keskinoğlu P, Olgun N. - Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients.
J Child Neurol. 2024 Oct;39(11-12):386-394. Altun Z, Ceyhan M, Yuan H, Kizmazoglu D, Aktas S, Olgun N. - Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma
Gene. 2023 Apr 15;860:147233. Altun Z, Yuan H, Baran B, Aktaş S, Sönmez EE, Küçük C, Olgun N. - The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants.
Am J Cancer Res. 2023 Sep 15;13(9):3854-3863. Olgun HN, Arayici ME, Cecen RE, Basbinar Y, Ellidokuz H. - Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patient
Clin Med Insights Oncol. 2023 Sep 19;17:11795549231199926. Baran B, Sanlav G, Kizmazoglu D, Kum Ozsengezer S, Aktas S, Altun Z, Olgun N. - Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies
Front Biosci (Landmark Ed). 2023 Aug 17;28(8):171. Aktas T, Kizmazoglu D, Aktas S, Erol A, Serinan E, Gokbayrak O, Ozdemir SM, Altun Z, Ozer E, Cecen E, Ince D, Olgun N. - Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience.
Front Oncol. 2022 Dec 23;12:1041443 Olgun N, Cecen E, Ince D, Kizmazoglu D, Baysal B, Onal A, Ozdogan O, Guleryuz H, Cetingoz R, Demiral A, Olguner M, Celik A, Kamer S, Ozer E, Altun Z, - Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group.
J Cancer Res Ther. 2017 Apr-Jun;13(2):284-290. Aksoylar S, Varan A, Vergin C, Hazar V, Akici F, Dagdemir A, Buyukavci M, Kebudi R, Kurucu N, Sevinir B, Unal E, Vural S, Guler E, Apak H, Oniz H, Kar - Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
Pediatr Hematol Oncol. 2003 Apr-May;20(3):211-8. Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca I, Arika
